We are in the process of conducting a Regulation A+ offering of our Class A Common Stock and have applied for the listing of our shares on Nasdaq. The offering and listing are expected to occur by the end of May.

Monogram has kicked off the process of moving forward with a public listing to trade on NASDAQ Investors can submit their allocation requests and we can begin the formal allocation of shares by accepting requests with our broker dealer by visiting monogramorthopedics.com.

The price per share is $7.25 and the minimum purchase is 150 shares or $1087.50.

The pre money valuation for the offering is $246M.

We are applying to list our shares for trading on Nasdaq. Once approved the shares will trade on day following the closing of the offering.

Monogram intends to list its Class A Common Stock.

We intend to market the offering for about 60 days. Please note that the shares issued in this offering would not be subject to a lockup. Additionally, on the first day of trading, we anticipate that you will be able to buy more shares in the open market on most trading platforms such as Robinhood, Fidelity, E-Trade or whatever your favorite broker might be. Once the bankers and the Company have determined that we may proceed with the offering, the Company will complete the public listing process and formally notify NASDAQ. The closing will then occur, and trading will begin the next business day.

Please note that SEC Rule 144 mandates that shares purchased under Reg CF (Regulation Crowdfunding) are not eligible for immediate trading and have a 12-month required lock-up period starting from when the investment closed. Equity Stock Transfer has records of when any Reg-CF series-C investments closed. 

Not at this time.

Transfer agents maintain a record of ownership, including contact information, of an issuer’s registered stockholders. After the Class A Common Stock is listed on NASDAQ, you will be able to deposit any shares into which your Preferred Stock converts with a broker. Until you deposit your shares in a brokerage account, the transfer agent will maintain the record of your ownership. Once you deposit your shares with a broker, the broker will maintain that record.

Monogram’s transfer agent is Equity Stock Transfer. Stockholders who purchased Preferred Stock will be able to convert their Preferred Stock into Common Stock through Equity Stock Transfer. If you’re a holder of Preferred Stock, please follow the step-by-step instructions to transfer your free trading shares to the broker of your choice - once the Company is listed on Nasdaq:

You will need to contact your broker and request to have your shares transferred. Once you have registered and created your username and password, through the Online Access portal, you will be able to download your Common Stock book-entry statement along with a Welcome Letter on how to initiate the process through your broker.

State law governs the Company’s obligations to surrender stock to the state if it cannot locate a shareholder after a period of time. Thus, shareholders are encouraged to keep their addresses up to date with the transfer agent.

Monogram is a C-Corp and, therefore, does not issue K-1’s.

The Series A Preferred Stock purchased through SeedInvest are held in street name by New Direction IRA, Inc. Therefore, if you purchased stock through SeedInvest, you will need to work through SeedInvest to convert your stock to Class A Common Stock in order to trade the shares after the Company is listed on Nasdaq. The contact email for SeedInvest is: contactus@seedinvest.com. 

Shares purchased through StartEngine are held by our transfer agent. You will be able to manage your shares directly through the transfer agent, Equity Stock Transfer.

Please note that SEC Rule 144 mandates that shares purchased under Reg CF (Regulation Crowdfunding) are not eligible for immediate trading and have a 12-month required lock-up period starting from when the investment closed. Equity Stock Transfer has records of when any Reg-CF series-C investments closed. 

We are based in the heart of Austin Texas.The corporate address is 3913 Todd Lane, Austin, TX 78744

We are a Delaware corporation.

All of Monogram’s regulatory filings, include financial reports, can be found here: EDGAR Entity Landing Page (sec.gov)

Please visit Monogram Orthopedics

Please visit Monogram Orthopedics

Email: invest@monogramorthopedics.com

Tel: (512)790-5151

Please visit: https://www.sec.gov/Archives/edgar/data/1769759/000110465923024829/tm237645d1_partiiandiii.html